Rheumatology Highlights 2020–2021
Studies show immunosuppressants do not significantly alter risk for worse COVID-19 outcomes.
New grant-funded research works to unlock the intricacies of Behcet’s disease.
Dr. H. Michael Belmont effectively treats a patient with lupus facing thrombocytopenia and anemia.
The studies’ span speaks to NYU Langone’s strong ability to lead multicenter trials in rheumatology.